Stelara dosing for psoriasis?

Stelara Dosage for Psoriasis: A Patient's Guide

To treat moderate to severe plaque psoriasis, Stelara (ustekinumab) is administered through a series of injections or infusions [1]. Understanding the correct dosing for Stelara is essential to effectively managing the condition. Stelara dosing for psoriasis involves multiple steps.

Why is Stelara Used for Psoriasis?

Stelara is a biologic medication that works by targeting specific proteins in the body that cause inflammation and immune system activation, which are key factors in psoriasis development [2]. By blocking these proteins, Stelara reduces the symptoms of psoriasis, including scaling, redness, and pain.

Dosing Guidelines for Stelara in Psoriasis

Stelara dosing for psoriasis typically begins with an initial subcutaneous injection of 45 mg, followed by a second dose 4 weeks later [3]. For patients who respond well to the initial dose, maintenance therapy involves injections every 12 weeks.

What Happens if I Miss a Dose?

If you miss a scheduled dose, it's essential to contact your healthcare provider for advice on resuming treatment. Missing doses can compromise the effectiveness of Stelara and may prolong the recovery process.

Can I Get a Biosimilar Version of Stelara?

Currently, there are no biosimilar versions of Stelara available on the market [4]. However, as patent law and pharmaceutical innovation continue to evolve, we may see new alternatives emerge in the future.

When Does Exclusivity Expire for Stelara?

According to patent information from DrugPatentWatch.com, Stelara's exclusivity is set to expire on [insert expiration date here] [5]. This may lead to the introduction of generics or biosimilars, but it's essential to stay updated with the latest information on this topic.

Patient Concerns and Side Effects

While Stelara can be effective in treating psoriasis, some patients may experience side effects, including redness, itching, and swelling at the injection site [6]. Rarely, Stelara can cause more severe reactions, such as infection or allergic reactions. It's crucial to report any concerns or side effects to your healthcare provider.

Who Makes Stelara?

Stelara is manufactured by Janssen Biotech, a subsidiary of Johnson & Johnson. This pharmaceutical company is committed to providing high-quality biologics, including Stelara, for the treatment of various conditions.

Sources:

[1] Janssen Biotech. (n.d.). STELARA Prescribing Information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125261s000lbl.pdf

[2] National Psoriasis Foundation. (n.d.). What is Psoriasis? Retrieved from https://www.psoriasis.org/psoriasis/

[3] Stelara Patient Information. (n.d.). Retrieved from https://www.stelara.com/what-is-stelara/about-stelara/

[4] GoodRX. (n.d.). Biosimilar and Generics for Psoriasis. Retrieved from https://www.goodrx.com/condition/psoriasis

[5] DrugPatentWatch.com. (n.d.). Ustekinumab (STELARA) Patents. Retrieved from https://www.drugpatentwatch.com/usp/stelara/patents

[6] National Institute of Arthritis and Musculoskeletal and Skin Diseases. (n.d.). Psoriasis. Retrieved from https://www.niams.nih.gov/health-topics/psoriasis